FDA has received yet more conflicting citizen petitions on telehealth abortion and mifepristone access, with Democratic state attorneys general asking the agency to use its enforcement discretion to continue allowing remote prescribing of abortion drugs while anti-abortion advocates ask it to consider removing mifepristone from the market altogether.
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us